TL;DR
This study demonstrates that both human and mouse tissue-engineered small intestines (TESI) successfully recapitulate key structural and functional aspects of native intestinal tissue. This is a crucial step towards developing TESI as a viable therapeutic alternative for patients suffering from short bowel syndrome (SBS).
What Problem Does This Paper Address?
Short bowel syndrome (SBS) is a severe condition where a significant portion of the small intestine is lost, leading to malnutrition and dependence on intravenous nutrition. Current treatments, like intestinal transplantation, face challenges such as donor scarcity and the need for lifelong immunosuppression. Tissue-engineered small intestine (TESI) offers a promising alternative, aiming to create functional intestinal tissue from a patient's own cells, thus avoiding these limitations. While previous work showed TESI could be generated and histologically resembled native intestine, its actual digestive and absorptive functions remained largely uncharacterized. This paper addresses this gap by rigorously evaluating the functional capabilities of both human and mouse TESI ex vivo.
Methods
The researchers utilized a previously established protocol to generate organoid units (OUs) from both mouse and human small intestinal tissue. These OUs were then implanted into host mice (genetically identical for mouse OUs and immunodeficient for human OUs) for four weeks. After this implantation period, the resulting TESI constructs were harvested and subjected to a battery of analyses:
- Transmission Electron Microscopy (TEM): To examine ultrastructural details of the epithelium, including tight junctions, microvilli, and cellular components.
- Immunohistochemistry and Immunofluorescence: To identify and localize specific proteins crucial for intestinal function, such as tight junction proteins (ZO-1), cytoskeletal components (actin), ion transporters (Na+/K+-ATPase, NHE1, NHE3, CFTR), water channels (aquaporin 7), and brush-border enzymes (sucrase isomaltase, SGLT-1).
- Histological Staining (Alcian Blue, Hematoxylin and Eosin): To visualize goblet cells and overall tissue architecture.
- In Vitro Enzyme Assays: To quantify the activity of key digestive enzymes like maltase and sucrase isomaltase, and intestinal alkaline phosphatase (IAP).
- Cell Proliferation Assays (Ki-67 staining): To identify actively dividing cells and assess the presence of stem/progenitor cell populations.
The study also included comparisons with native mouse jejunum and human ileum as controls to validate the findings.
Datasets
The study did not utilize pre-existing datasets for training or evaluation. Instead, it generated its own experimental data through ex vivo analysis of tissue-engineered constructs and native intestinal tissue. The "datasets" in this context are the harvested TESI and control tissue samples, which were then analyzed using the described microscopy and biochemical assays.
Key Insights and Ideas
- Functional Equivalence: The most striking insight is the demonstration that both human and mouse TESI exhibit remarkably similar functional capabilities, mirroring native intestinal tissue. This suggests that the underlying mechanisms of tissue engineering are conserved across species and that mouse models can reliably predict human TESI function.
- Polarized Epithelium: TESI successfully forms a well-polarized epithelium with distinct apical and basolateral domains, essential for directional transport and absorption. This is evidenced by the correct localization of key transporters and channels.
- Intact Barrier Function: The presence of intact tight junctions (ZO-1) in TESI is a critical finding, indicating the formation of a functional intestinal barrier, which is vital for preventing unwanted leakage and maintaining homeostasis.
- Digestive Machinery: The expression and activity of key brush-border enzymes (maltase, sucrase, SGLT-1) and transporters (NHEs, CFTR, aquaporins) confirm that TESI possesses the necessary machinery for nutrient digestion and absorption.
- Stem Cell Niche: The presence of Ki-67 positive cells, indicative of proliferating progenitor cells, within the crypt-like structures of TESI suggests the successful recapitulation of the stem cell niche, crucial for continuous tissue renewal.
- Cdc42's Role: The colocalization of Cdc42 with secretory cell types (goblet and Paneth cells) in TESI, mirroring native tissue, highlights the conserved role of this small GTPase in intestinal homeostasis and function.
Key Results
- Ultrastructural Similarity: TEM revealed that TESI epithelium possesses major ultrastructural components like tight junctions and microvilli, comparable to native intestine.
- Protein Localization: Immunohistochemistry confirmed the correct apical localization of transporters like SGLT-1, CFTR, and aquaporin 7, and basolateral localization of Na+/K+-ATPase in TESI, mirroring native tissue.
- Enzyme Activity: While functional assays showed that maltase and sucrase activity in TESI was lower than in native controls (likely due to the absence of luminal flow and pancreatic enzymes), the enzymes were demonstrably active. Intestinal alkaline phosphatase (IAP) showed strong activity at the brush border.
- Cellular Composition: TESI contained goblet cells (identified by Alcian Blue staining), Paneth cells, enterocytes, and enteroendocrine cells, consistent with native intestinal tissue.
- Proliferation: Ki-67 staining indicated the presence of rapidly dividing cells in both epithelial and mesenchymal compartments of TESI, suggesting ongoing tissue development and the presence of progenitor cells.
Limitations and Future Work
- Ex Vivo Limitations: The study acknowledges that ex vivo analysis, while informative, cannot fully replicate the complex in vivo environment, particularly the influence of luminal flow, mechanical forces, and the presence of a microbiome.
- Enzyme Activity: The reduced enzymatic activity of maltase and sucrase in TESI compared to native tissue is attributed to the lack of luminal contents and activating enzymes.
- Small Animal Model Constraints: The small size of the TESI constructs in mouse models limits the types of in vivo functional experiments that can be performed, such as tensile strength testing or Ussing chamber experiments.
- Future Directions: The authors suggest that larger animal models will be necessary to further investigate TESI function, including motility, and to pave the way for clinical applications in infants and children with intestinal failure. They also highlight the utility of this model for identifying morphogens that could improve TESI growth and for investigating stem/progenitor cell behavior. The consistent results between human and mouse TESI strongly support the use of mouse models for pre-clinical studies of human TESI.
Summary updated